Top 3 RCM Mergers and Acquisitions for Q1 and Q2 of 2024

January 2024

Chicago, Illinois, January 17 , 2024 R1 RCM Inc. (NASDAQ: RCM), based in Murray, Utah, has completed its acquisition of Acclara from Providence. This strategic move, valued at $675 million, includes both cash and a warrant for up to 12.2 million shares of R1 stock. R1 RCM aims to significantly enhance its revenue cycle management services through this acquisition. Acclara, known for its modular RCM services, is anticipated to generate over $625 million in revenue and contribute $185 million to Adjusted EBITDA within five years.The acquisition is financed through new Term B Loans, the existing revolver, and cash on hand. 

Houston, January 9, 2024 – Elevate Patient Financial Solutions (ElevatePFS) has announced its acquisition of Professional Medical Services, a company specializing in revenue cycle management (RCM) solutions for low-balance accounts receivable resolution. This strategic move aims to broaden ElevatePFS’ suite of RCM offerings and address complex revenue cycle issues for hospitals and health systems. The acquisition underscores ElevatePFS' commitment to enhancing cash collections and financial performance through advanced technology and specialized expertise.

March 2024

San Diego, California, March 6, 2024 – Frazier Healthcare Partners has acquired RevSpring, a leader in patient communication and financial engagement solutions, marking a significant enhancement to its revenue cycle management (RCM) and medical billing capabilities. RevSpring’s advanced technologies in patient billing and financial management will now integrate with Frazier’s existing RCM offerings, streamlining billing processes and improving financial interactions for healthcare providers. This strategic acquisition reflects Frazier’s commitment to advancing its RCM solutions, reducing billing errors, accelerating payment processes, and ultimately driving better financial outcomes for healthcare organizations.

New York, March 4, 2024– WindRose Health Investors has recently acquired CardioOne, a prominent player in revenue cycle management (RCM) for cardiology practices. This strategic acquisition significantly enhances WindRose’s capabilities in medical billing and RCM, particularly within the cardiology sector. CardioOne’s expertise in managing the complexities of cardiology billing processes will now be integrated into WindRose’s broader RCM solutions, aiming to streamline billing operations, improve financial performance, and optimize revenue cycles for cardiology practices.. This move underscores WindRose’s commitment to strengthening its position in the RCM market by offering more specialized and efficient billing solutions tailored to the unique needs of cardiology.

June 2024

Provana has strategically expanded its revenue cycle management (RCM) capabilities through a series of mergers and acquisitions (M&A).Provana acquired five specialized RCM firms Account Matters,CIS, To the Point Billing Solutions , ACI Therapy Billing  ,Central Iowa Medical Billing, Inc These strategic acquisitions significantly enhance Provana's service offerings, providing a more robust and comprehensive RCM solution. This move also strengthens Provana's market position within the healthcare sector. By integrating these companies, Provana aims to provide more comprehensive and efficient RCM solutions to its clients, leveraging advanced analytics and a global workforce.

June 10, 2024 – Med-Metrix has announced the acquisition of Health Business Consulting Services (HBCS), a strategic move that significantly enhances its revenue cycle management (RCM) capabilities. By integrating HBCS’s comprehensive suite of RCM services, including billing and coding, Med-Metrix aims to create a more streamlined and efficient end-to-end RCM platform. This acquisition strengthens Med-Metrix’s position in the healthcare financial services market, providing healthcare organizations with advanced tools to optimize billing processes and improve revenue cycle management, ultimately leading to better financial outcomes.